Annual Review Course (2016)

New Orleans, LA US
June 23, 2016 to June 25, 2016

In preparation for the American Board of Urology (ABU) Qualifying (Part 1) Examination, residents need to have basic urologic knowledge to prepare them for the ABU examinations. To fulfill this need, the American Urological Association (AUA) developed this course to disseminate current urologic knowledge. This course may also be of interest to practicing urologist preparing for the Recertification Examination as well as others, including allied health professionals, looking for a thorough review of basic urologic topics.

Target Audience

  • APN/PA
  • Resident
  • Urologist

Learning Objectives

At the conclusion of this course, participants will be able to:

  1. Apply basic, generally-accepted urological practices for superior patient care.
  2. Demonstrate core knowledge of urology necessary for Part I of the American Board of Urology (ABU) qualifying examination and for the recertification examination.
Course summary
Available credit: 
  • 26.25 AMA PRA Category 1 Credit™
  • 26.25 Non-Physician Participation
Course opens: 
03/30/2016
Course expires: 
06/25/2019
Event starts: 
06/23/2016 - 7:30am
Event ends: 
06/25/2016 - 5:00pm
Price:
$1,295.00
Rating: 
0

Thursday, June 23, 2016

6:30 a.m.                              Registration/Breakfast

7:30 a.m.                              Introduction

                                                Howard B. Goldman, MD and Robert G. Uzzo, MD

PROSTATE CANCER AND BPH

7:45 a.m.                              Adam S. Kibel, MD

  • Diagnosis and Screen, Staging, Imaging (including PSA Screening Controversies)

  • Treatment of Localized Cancer (U.S. Stages A and B), Watchful Waiting, Radiation, Interstitial Irradiation, Surgery, Cryosurgery and Hormonal Therapy)

  • Treatment of Advanced Cancer (U.S. Stages C and D) and Treatment of Radiation Failure

PEDIATRIC UROLOGY

9:15 a.m.                              Armando J. Lorenzo, MD

                                                Pediatric Urological Oncology

  • Wilm’s Tumor and Other Renal Tumors

  • Rhabdomyosarcoma

  • Neuroblastoma

  • Testis Tumors

                                                Andrew J. Kirsch, MD

                                                Pediatric Urinary Incontinence and Bladder Disorders

· Voiding Dysfunction and Neurogenic Bladder

· Developmental Anomalies of the Bladder     

· Urinary Tract Infection and Reflux

· Management of Neurogenic and Non-Neurogenic Bladder

10:45 a.m.                           Break

11:00 a.m.                           Armando J. Lorenzo, MD

                                                Disorders of the Genitalia

  • Intersex

  • Hypospadias

  • Epispadias-Exstrophy

  • Undescended Testicle, Hydroceles, Hernias

Andrew J. Kirsch, MD   

Congenital Urinary Tract Abnormalities

  • UPJ Obstruction, UVI Obstruction (megaureter)

  • Ureteroceles

  • Cystic Disease

  • Posterior Urethral Valves

  • Prune Belly Syndrome

  • Vesicoureteral Reflux

12:15 p.m.                           Lunch  

1:15 p.m.                             Pediatric Case Studies

                                                Andrew J. Kirsch, MD and Armando J. Lorenzo, MD

UROLOGIC TRAUMA

2:00 p.m.                             Allen F. Morey, MD

  • Renal and Ureteral Trauma: Evaluation and Management

  • Bladder and Urethral Trauma: Evaluation and Management

  • Genital Trauma: Evaluation and Management

3:15 p.m.                             Break  
 

UROLITHIASIS

3:30 p.m.                             Glenn M. Preminger, MD

  •  Epidemiology, Pathophysiology

  •  Evaluation and Medical Management

4:15 p.m.                             Peter G. Schulam, MD, PhD

  • Surgical Management of Stone Disease

LAPAROSCOPY

4:45 p.m.                             Peter G. Schulam, MD, PhD

  • Physiology and Complications

5:30 p.m.                             Meeting Adjourns for the Day

Friday, June 24, 2016

6:30 a.m.                              Breakfast

FEMALE UROLOGY, URODYNAMICS AND NEUROUROLOGY

7:00 a.m.                              Stephen R. Kraus, MD

  • Urodynamics Review

  • Neurourology

8:00 a.m.                              Howard B. Goldman, MD

  • Overactive Bladder/Urgency Incontinence

  • Stress Urinary Incontinence

  • Pelvic Organ Prolapse

  • Vaginal Masses/Urethral Diverticulum

  • Urinary Fistula

9:15 a.m.                              Incontinence Case Studies (Panel)

                                               Stephen R. Kraus, MD and Howard B. Goldman, MD

9:30 a.m.                              Break

RENAL MEDICINE

9:45 a.m.                              Daniel A. Shoskes, MD

  • Renal Transplantation

  • Renal Vascular Disease

  • Renal Physiology (including Fluid and Electrolytes)

URINARY TRACT INFECTION

11:15 a.m.                           Duane R. Hickling, MD

12:15 p.m.                           Lunch

INFECTION AND INFLAMMATION

1:15 p.m.                             Daniel A. Shoskes, MD

  • Interstitial Cystitis

  • Sexually Transmitted Diseases (Gonorrhea, Chlamydia, AIDS and others)

ADRENAL

2:00 p.m.                             Jay T. Bishoff, MD

  • Epidemiology, Diagnosis and Imaging (including Cushings, Hyperaldosteronism, Pheochromocytoma, Cancer and the Incidentally Found Adrenal Mass)

  • Management (including Pheochromocytoma, Cancer, Hyperaldosteronism, Incidentaloma and Metastatic Disease)

2:45 p.m.                             Break

ANATOMY AND EMBRYOLOGY

3:00 p.m.                             Howard B. Goldman, MD

  • Applied Anatomy

  • Embryology

GU RADIOLOGY

4:45 p.m.                             Brian R. Herts, MD

  • Basics of MR, CT and US

  • Solid and cystic renal masses (CT and MR)

  • Transitional cell carcinoma

  • Prostate MR

  • Adrenal imaging

  • Scrotal imaging

  • Retroperitoneal tumors

  • Radiation basic principles

6:00 p.m.                             Meeting Adjourns for the Day

Saturday, June 25, 2016

6:30 a.m.                              Breakfast

PENILE AND URETHRAL CANCER

7:00 a.m.                              Robert G. Uzzo, MD

  • Epidemiology

  • Diagnosis and Staging

  • Imaging and Treatment

BLADDER CANCER

7:30 a.m.                              Michael A. O’Donnell, MD

  • Epidemiology, Anatomy, Diagnosis and Imaging

  • Treatment of NMIBC/ Superficial Disease Managment

  • Bladder Cancer test questions

8:30 a.m.                              Seth P. Lerner, MD, FACS

  • Staging and risk stratification of muscle invasive bladder cancer

  • Multidisciplinary treatment including radical cystectomy, lymphadenectomy, peri-operative chemotherapy and chemoradiation therapy

  • Other bladder sparing treatments

  • Treatment of metastatic disease

  • Incontinent and continent urinary diversion techniques

10:00 a.m.                           Break

RENAL AND URETERAL TUMORS

10:15 a.m.                          Robert G. Uzzo, MD

  • Epidemiology, Anatomy, Diagnosis and Imaging (Including Evaluation of Renal Masses)

  • Treatment of Localized Disease (including Role of Partial Nephrectomy)

  • Treatment of Metastatic Disease

  • Transitional Cell Carcinoma

11:30 a.m.                           Exam Overview, Test Taking Logistics, and ABU Process

                                                J. Christian Winters, MD

12:00 p.m.                           Lunch

1:00 p.m.                             AUA Update: Core Curriculum

                                              John P. Mulhall, MD      

TESTICULAR TUMORS

1:15 p.m.                            Wade J. Sexton, MD

  • Epidemiology, Diagnosis, Staging and Imaging (including the Role of Markers and CIS)

  • Treatment of Seminoma

  • Treatment of Non-seminomatous Germ Cell Tumors (including Controversy Regarding Stage A Management, Risk Factors for Recurrence, Algorithms for Stages A,B, and C)

ERECTILE DYSFUNCTION

2:30 p.m.                             John P. Mulhall, MD

  • Physiology of Erection, Pathophysiology of Erectile Dysfunction

  • Evaluation and Management of Erectile Dysfunction

  • Pathophysiology, Evaluation and Management of Priapism Pathophysiology, Evaluation and Management of Peyronie’s Disease

INFERTILITY

3:30 p.m.                             Paul J. Turek, MD

  • Physiology and Pathophysiology of Male Reproduction

  • Evaluation of the Infertile Male

  • Treatment of the Infertile Male (Surgical and Non-surgical)

  • Hypogonadism

  • Testosterone Replacement

 5:00 p.m.                             Meeting Adjourns for the Day

The Roosevelt Hotel
130 Roosevelt Way
New Orleans, LA 70112
United States

To hold a reservation, a major credit card number must be provided.
$196 single/double occupancy.  Make your reservation online or call 1-800-925-3673.  Reference the group code when making your reservation to receive the special group rate. Group Code: ARC

Cut-off Date: Wednesday, June 1, 2016.
Once the AUA group block is full, which may be prior to the cut-off date, the AUA is unable to guarantee rooms at this rate or at this hotel.

Check-in: 3 pm
Check-out: Noon

Glenn M. Preminger, MDSpeaker

Nothing to Disclose

   
Gary E. Lemack, MDSpeaker

Roivant

Consultant or Advisor

Yes

11/17/2017

Armando J. Lorenzo, MDSpeaker

Nothing to Disclose

   
Howard B. Goldman, MDSpeaker

Axonics

NewUro

Galvani

Consultant or Advisor

Consultant or Advisor

Consultant or Advisor

Yes

Yes

Yes

04/04/2017

10/31/2017

01/15/2018

Peter G. Schulam, MDSpeaker

Nothing to Disclose

   
Paul J. Turek, MDSpeaker

Contraline, Inc

FutureFamily, Inc

Consultant or Advisor

Consultant or Advisor

Yes

Yes

10/18/2017

10/18/2017

Andrew Jared Kirsch,M.D.Speaker

Nothing to Disclose

Victor W. Nitti, MDSpeaker

Medtronic

Scientific Study or Trial

No

04/03/2017

Daniel A. Shoskes, MDSpeaker

Aquinox

Consultant or Advisor

Yes

04/03/2017

Jay T. Bishoff, MDSpeaker

Nothing to Disclose

   
Robert G. Uzzo, MDSpeaker

Nothing to Disclose

   
Michael A. O'Donnell, MDSpeaker

Nothing to Disclose

   
Seth P. Lerner, MD, FACSSpeaker

Nothing to Disclose

   
Duane R. Hickling, M.D.Speaker

Pfizer

Consultant or Advisor,Meeting Participant or Lecturer

Yes

07/20/2017

John P. Mulhall, MDSpeaker

Nothing to Disclose

   
Stephen R. Kraus, MDSpeaker

Nothing to Disclose

   
Howard B. Goldman, MDSpeaker

Axonics

NewUro

Galvani

Consultant or Advisor

Consultant or Advisor

Consultant or Advisor

Yes

Yes

Yes

04/04/2017

10/31/2017

01/15/2018

Adam S. Kibel, MDSpeaker

Janssen

ConfirmMDx

Pfizer

Consultant or Advisor

Consultant or Advisor

Consultant or Advisor

Yes

Yes

Yes

11/12/2017

11/12/2017

03/16/2018

Wade Jeffers Sexton , M.D.Speaker

Nothing to Disclose

   
Jay Simhan, MDSpeaker

Nothing to Disclose

   
Brian Herts ,M.D.Speaker

Siemens Healthineers

Scientific Study or Trial

No

10/23/2017

Accreditation: The American Urological Association (AUA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation: The American Urological Association designates this live activity for a maximum of 26.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Other Learners: The AUA is not accredited to offer credit to participants who are not MDs or DOs. However, the AUA will issue documentation of participation that states that the activity was certified for AMA PRA Category 1 Credit™.

Evidence Based Content: It is the policy of the AUA to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.

AUA Disclosure Policy: All persons in a position to control the content of an educational activity (i.e., activity planners, presenters, authors) are required to disclose to the provider any relevant financial relationships with any commercial interest. The AUA must determine if the individual’s relationships may influence the educational content and resolve any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners information with which they can make their own judgments.

Resolution of Identified Conflict of Interest: All disclosures will be reviewed by the program/course directors or editors for identification of conflicts of interest. Peer reviewers, working with the program directors and/or editors, will document the mechanism(s) for management and resolution of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to resolve conflict of interest:

  • Peer review for valid, evidence-based content of all materials associated with an educational activity by the course/program director, editor, and/or Education Content Review Committee or its subgroup.
  • Limit content to evidence with no recommendations
  • Introduction of a debate format with an unbiased moderator (point-counterpoint)
  • Inclusion of moderated panel discussion
  • Publication of a parallel or rebuttal article for an article that is felt to be biased
  • Limit equipment representatives to providing logistics and operation support only in procedural demonstrations
  • Divestiture of the relationship by faculty

Off-label or Unapproved Use of Drugs or Devices: The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.

Available Credit

  • 26.25 AMA PRA Category 1 Credit™
  • 26.25 Non-Physician Participation

Accreditation Period

Course opens: 
03/30/2016
Course expires: 
06/25/2019

Price

Price:
$1,295.00
Please login or register to take this course.